OOIR: Observatory of International Research

Papers

(The TQCC of Familial Cancer is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Ninth International Symposium on Hereditary Breast and Ovarian Cancer	37
Screening for pancreatic cancer in high-risk individuals using MRI: optimization of scan techniques to detect small lesions	32
Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center	26
In memoriam Professor Thierry Frébourg	21
2022 CGA-IGC Annual Meeting: The collaborative group of the Americas on Inherited Gastrointestinal Cancer November 11–13, 2022	20
Balancing the burden and benefits of colonoscopy in Lynch Syndrome	14
Endoscopic screening for identification of signet ring cell gastric cancer foci in carriers of germline pathogenic variants in CDH1	14
Identifying the BRCA1 c.-107A > T variant in Dutch patients with a tumor BRCA1 promoter hypermethylation	13
Identification of a germline deep intronic PTEN-deletion leading to exonization through whole genome and targeted RNA sequencing	13
The Italian registry of families at risk for pancreatic cancer (IRFARPC): implementation and evolution of a national program for pancreatic cancer surveillance in high-risk individuals	12
Recurring pathogenic variants in the BRCA2 gene in the Ethiopian Jewish population. Founder mutations?	12
The best linear unbiased prediction (BLUP) method as a tool to estimate the lifetime risk of pancreatic ductal adenocarcinoma in high-risk individuals with no known pathogenic germline variants	12
In deep bioinformatic characterization of a novel fumarate hydratase variant FH c.199T > G; (p.Tyr67Asp) in hereditary leiomyomatosis and renal cell carcinoma	11
Germline p.R181H variant in TP53 in a family exemplifying the genotype-phenotype correlations in Li-Fraumeni syndrome	11
A pilot study investigating feasibility of mainstreaming germline BRCA1 and BRCA2 testing in high-risk patients with breast and/or ovarian cancer in three tertiary Cancer Centres in Ireland	11
Re-evaluating cancer risks associated with the CHEK2 p.Ser428Phe Ashkenazi Jewish founder pathogenic variant	11
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X family	10
Endoscopic indicators in patients with familial adenomatous polyposis undergoing duodenal resections – a nationwide Danish cohort study with long-term follow-up	10
A patient with very early onset FH-deficient renal cell carcinoma diagnosed at age seven	8
PTCH2 is not a strong candidate gene for gorlin syndrome predisposition	8
Correction to: Letter to the Editor—Recent advances in Lynch syndrome	7
Physicians’ experience, practice and education, on genetic testing and genetic counseling: a nationwide survey study in Greece	7
Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake	6
Thirty-year compliance with a surveillance program for patients with familial adenomatous polyposis	6
Correction: Clinician perspectives on policy approaches to genetic risk disclosure in families	6

Barriers to completion of cascade genetic testing: how can we improve the uptake of testing for hereditary breast and ovarian cancer syndrome?	6
Outcomes of retesting in patients with previously uninformative cancer genetics evaluations	6
Aspects and outcomes of surveillance for individuals at high-risk of pancreatic cancer	6
CGA-IGC 2023 Abstracts	5
Strategies for diagnosis and management of CMMRD in low-resource countries: report of a Tunisian family	5
The response of pancreatic acinar cell carcinoma to platinum and olaparib therapy in a germline BRCA2 variant carrier: case report and literature review	5
Men with metastatic prostate cancer carrying a pathogenic germline variant in breast cancer genes: disclosure of genetic test results to relatives	5
Utility of interim blood tests for cancer screening in Li-Fraumeni syndrome	5
Prevalence of cardiometabolic outcomes in women who underwent salpingo-oophorectomy to prevent hereditary breast and ovarian cancer: a meta-analysis	5
A comprehensive characterization of the spectrum of MUTYH germline pathogenic variants in Latin America	5
Von Hippel-Lindau disease and rapidly progressing pheochromocytomas in siblings	5
Willingness of individuals with Li-Fraumeni syndrome to participate in a cancer prevention trial: a survey study	5
Truncating TINF2 p.Tyr312Ter variant and inherited breast cancer susceptibility	5
The paradigm of hematological malignant versus non-malignant manifestations, driven by primary immunodeficiencies: a complex interplay	5
Cascade genetic testing: an underutilized pathway to equitable cancer care?	5
In memoriam: Gloria Petersen, PhD (1950-2023)	5
Li Fraumeni Syndrome predisposes to gastro-esophageal junction tumours	5
Laboratory variation in the grading of dysplasia of duodenal adenomas in familial adenomatous polyposis patients	5
Healthcare professionals’ perspectives on implementation of universal tumor DNA testing in ovarian cancer patients: multidisciplinary focus groups	4
Detecting inversions in routine molecular diagnosis in MMR genes	4
A family-based approach to cascade genetic testing in a pediatric cancer genetics clinic	4
Review of the cost-effectiveness of surveillance for hereditary pancreatic cancer	3
Correction: Outcomes of retesting in patients with previously uninformative cancer genetics evaluations	3
Colonoscopy surveillance in Lynch syndrome is burdensome and frequently delayed	3
Preimplantation genetic testing in patients with genetic susceptibility to cancer	3
Constitutional 2p16.3 deletion including MSH6 and FBXO11 in a boy with developmental delay and diffuse large B-cell lymphoma	3
Clinical and imaging modality factors impacting radiological interpretation of breast screening in young women with neurofibromatosis type 1	3
Sarcomas arising in MEN1 patients: demonstrating LOH of the MEN1 locus and loss of menin expression	3
Myelodysplastic syndrome with dual germline RUNX1 and DDX41 variants: a rare genetic predisposition case	3
Challenges and opportunities for Lynch syndrome cascade testing in the United States	3
A case of Rothmund-Thomson syndrome originally thought to be a case of Bloom syndrome	3
A de novo pathogenic variant in the MSH6 gene in a 52 years-old woman	3
Expanding access to genetic testing for pancreatic cancer	3
Case review of perivascular epithelioid cell tumor occurring in patients with Li-Fraumeni syndrome	3
Juvenile polyposis diagnosed with an integrated histological, immunohistochemical and molecular approach identifying new SMAD4 pathogenic variants	3
The psychological impact and experience of breast cancer screening in young women with an increased risk of breast cancer due to neurofibromatosis type 1	3
Fibroadenoma in vulval ectopic breast tissue in a patient with PTEN Hamartoma Tumour Syndrome	3